|
Q2 2019
Filed on Aug 09, 2019
|
5,005,278
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
33,600
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
10,400
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
6,600
|
N/A
|
|
Sienna Biopharmaceuticals
|
Q2 2019
Filed on Aug 09, 2019
|
13,500
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
4,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
92,200
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
1,600
|
$30.9 - $56.8
$49.4K - $90.9K
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
70,400
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
10,400
|
$2.06 - $3.11
$21.4K - $32.3K
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
19,400
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
800
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
5,500
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
18,200
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
20,600
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
11,800
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
16,100
|
$4.87 - $8.56
$78.4K - $138K
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
15,500
|
N/A
|
|
Nuverra Environmental Sol
|
Q2 2019
Filed on Aug 09, 2019
|
7,400
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
26,100
|
$1.37 - $1.85
$35.8K - $48.3K
|
|
Proteostasis Therapeutics
|
Q2 2019
Filed on Aug 09, 2019
|
25,100
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
13,200
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
8,000
|
$0.84 - $1.94
$6.72K - $15.5K
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
15,562
|
$1.26 - $1.74
$19.6K - $27.1K
|
|
Spring Bank Pharmaceutica
|
Q2 2019
Filed on Aug 09, 2019
|
12,300
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
16,000
|
$1.47 - $3.16
$23.5K - $50.6K
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
16,200
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
500
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
8,900
|
$9.7 - $16.02
$86.3K - $143K
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
25,300
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
33,800
|
$0.33 - $0.83
$11.2K - $28.1K
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
40,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
17,012
|
$2.37 - $3.97
$40.3K - $67.5K
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
122,397
|
$11.27 - $13.6
$1.38M - $1.66M
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
4,678,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
1,325,000
|
N/A
|
|
Spirit Realty Capital Inc
|
Q2 2019
Filed on Aug 09, 2019
|
7,750,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
1,711,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 09, 2019
|
1,200
|
$5.28 - $8.2
$6.34K - $9.84K
|
|
|
Q1 2019
Filed on May 08, 2019
|
14,697
|
N/A
|
|
|
Q1 2019
Filed on May 08, 2019
|
318,227
|
N/A
|
|
|
Q1 2019
Filed on May 08, 2019
|
34,800
|
N/A
|
|
|
Q1 2019
Filed on May 08, 2019
|
113,600
|
N/A
|
|
|
Q1 2019
Filed on May 08, 2019
|
79,300
|
N/A
|
|
|
Q1 2019
Filed on May 08, 2019
|
66,900
|
N/A
|
|
|
Q1 2019
Filed on May 08, 2019
|
19,700
|
N/A
|
|
|
Q1 2019
Filed on May 08, 2019
|
16,800
|
N/A
|
|
|
Q1 2019
Filed on May 08, 2019
|
65,300
|
N/A
|
|
Dun & Bradstreet Corp/The
|
Q1 2019
Filed on May 08, 2019
|
133,702
|
N/A
|
|
|
Q1 2019
Filed on May 08, 2019
|
56,100
|
N/A
|
|